What kinds of ADHD medication are used for teens, and how are they chosen?

Teens are usually offered two medication types

For adolescents, ADHD medication discussions usually centre on stimulant medications and non-stimulant options. Canadian Paediatric Society guidance says medication can be considered for children and youth age 6 and older, and it describes both stimulant and non-stimulant treatment, with benefits, risks, dosing and monitoring. (cps.ca)

In Canadian practice guidance, stimulants are generally the first medication class tried because they tend to improve core ADHD symptoms more strongly for many patients. Non-stimulants are commonly considered when stimulants are not tolerated, do not help enough, are not a good fit because of another clinical issue, or raise concerns about misuse or diversion. (cps.ca)

The choice depends on the teen’s pattern

Clinicians do not choose medication by diagnosis alone. They match the class and formulation to the teen’s actual pattern of problems, where the day breaks down, and what side effects would matter most at home, at school and after school.

• If the main problem is sustained attention through classes and homework, a long-acting formulation may be considered first.
• If impulsivity and emotional reactivity are causing conflict later in the day, duration of coverage matters, not just whether medication works in the morning.
• If appetite, weight, sleep or headaches are already fragile, side-effect risk may shape the starting choice and the pace of dose changes.
• If there is a history of misuse, diversion or substance-use concerns, Canadian guidance says a non-stimulant or an extended-release stimulant with lower misuse risk may be considered as part of a broader treatment plan.
• If tics, anxiety symptoms or another condition are part of the picture, the clinician looks at whether one class is more practical or better tolerated for that teen.

CADDRA states that, at the population level, the two stimulant subclasses have similar efficacy and tolerability, but an individual patient may respond to or tolerate one better than the other. That is why medication choice is often a careful trial process rather than a single obvious answer. (caddra.ca)

Long-acting options are often considered first

For teens, long-acting formulations are often practical because they can reduce the need for doses during the school day and may give steadier coverage across classes, homework and commuting. CADDRA recommends an adequate trial of both classes of long-acting stimulant medications before moving to second-line treatment, unless there is a reason not to use them. (caddra.ca)

That does not mean every teen should start the same way. Some adolescents need shorter coverage, a slower approach because of side effects, or a non-stimulant first because stimulants are not appropriate in their situation. Product monographs and marketed status can be checked in Health Canada’s Drug Product Database, which is updated regularly and links to current product monographs and safety updates. (canada.ca)

If access becomes confusing because a product is unavailable, checking with the pharmacist and prescriber can help clarify alternatives for the same medication class or formulation.

Side effects often shape the final choice

In real life, the final choice is often less about the label on the medication class and more about what the teen can actually tolerate. A medicine that helps attention but causes major appetite loss, insomnia or irritability may not be the right fit.

• Appetite and growth concerns, especially if the teen is already eating poorly or losing weight
• Sleep timing, especially if falling asleep is already hard
• Mood changes, rebound irritability or feeling flat
• Headaches, stomach upset, dizziness, blood pressure or pulse changes
• Privacy and safety concerns if a medication could be shared, lost or misused

The Canadian Paediatric Society notes that non-stimulants are second-line overall, but they may be useful when stimulants are contraindicated, ineffective or not tolerated. The same statement notes that some non-stimulants have lower abuse or diversion potential than stimulants. (cps.ca)

If a teen also has significant anxiety, depression, self-harm thoughts or substance-use concerns, those issues need direct assessment, not just a medication change. If someone needs help now, call or text 9-8-8 in Canada, or call 911 in an emergency.

Choosing medication is a monitored process

Medication selection for teens is usually a step-by-step process: set treatment goals, start low, adjust gradually, and monitor both benefit and side effects. CADDRA’s guideline lays out this sequence as setting treatment objectives, medication selection, titration and monitoring, then ongoing follow-up. (caddra.ca)

1. Confirm that the presentation is consistent with ADHD and check for coexisting issues that could change the plan. If that part is still unclear, start with How do I get my teen assessed for ADHD?.
2. Define target problems in plain terms, such as missed assignments, unsafe impulsivity, homework battles, driving concerns, or emotional blowups in the evening.
3. Choose a class and formulation that fits the teen’s daily schedule, risk factors and prior side effects.
4. Monitor with parent and teen feedback, and often school input when appropriate, then adjust.
5. Reassess if the medicine helps symptoms but the teen is still struggling with organisation, anxiety, sleep or family conflict.

The process matters because not every teen responds the same way, and not every assessment leads to medication. An online assessment, when offered by a licensed clinician using a structured process, can be one route to finding out whether ADHD is part of the picture. More on that is explained here: Can a teenager be assessed for ADHD online?.